An Evaluation of the Impact of Pharmacist Personalized Medication Reviews With and Without a Discussion of Pharmacogenomic Results in an Employee Health Program.

NAEnrolling by invitationINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions

PharmacogeneticsPharmacogenomic Drug Interaction

Interventions

OTHER

Pharmacist Personalized Medication Review (PMR)

Pharmacist-provided review of current medications and assessment of potential medication related problems.

OTHER

Discussion of Pharmacogenomic results during the PMR

Return of pharmacogenomic results and discussion of impact on medications.

Trial Locations (1)

University of Pittsburgh, Pittsburgh

All Listed Sponsors

collaborator

University of Pittsburgh Medical Center

OTHER

lead

University of Pittsburgh

OTHER